FDA's updated rules for drug advertising for TV and radio near the finish line
It’s been more than 10 years since the FDA last gathered public comments on TV and radio prescription drug advertising changes. But now it’s moving forward on a proposal aimed at making the ads more “clear, conspicuous and neutral.”
The Office of Management and Budget is reviewing the final rule, according to the Office of Information and Regulatory Affairs’ website, which would revise the regulations around how a drug’s most important risks are presented in ads. The rule change’s status was first reported by STAT.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
